Intraischemic nitrous oxide alters neither neurologic nor histologic outcome: A comparison with dizocilpine

Anesthesia and Analgesia

Volumn 99, Issue 3, 2004, Pages 896-903

  Yokoo, Noriko ^a   Sheng, Huaxin ^a   Mixco, Javier ^b   Homi, H Mayumi ^a   Pearlstein, Robert D ^a   Warner, David S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITROUS OXIDE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN OXYGEN TENSION; CONTROLLED STUDY; DRUG MECHANISM; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PRESSURE; DIZOCILPINE MALEATE; INTUBATION, INTRATRACHEAL; ISCHEMIC ATTACK, TRANSIENT; MALE; NITROUS OXIDE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; REGRESSION ANALYSIS;

EID: 4143114731     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000132973.32387.8B     Document Type: Article

References (41)

1. Maze M, Fujinaga M. Recent advances in understanding the actions and toxicity of nitrous oxide [editorial]. Anaesthesia 2000;55:311-4.
2. Jevtovic-Todorovic V, Todorovic S, Mennerick S, et al. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med 1998;4:460-3.
3. Mennerick S, Jevtovic-Todorovic V, Todorovic S, et al. Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci 1998;18:9716-26.
4. Daniell LC. The noncompetitive N-methyl-d-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics. Pharmacol Biochem Behav 1990;36:111-5.
5. Sarraf-Yazdi S, Sheng HX, Miura Y, et al. Relative neuroprotective effects of dizocilpine and isoflurane during focal cerebral ischemia in the rat. Anesth Analg 1998;87:72-8.
6. Scheller MS, Zornow MH, Fleischer JE, et al. The noncompetitive N-methyl-D-aspartate receptor antagonist, MK-801 profoundly reduces volatile anesthetic requirements in rabbits. Neuropharmacology 1989;28:677-81.
7. Kuroda Y, Strebel S, Rafferty C, Bullock R. Neuroprotective doses of N-methyl-D-aspartate receptor antagonists profoundly reduce the minimum alveolar anesthetic concentration (MAC) for isoflurane in rats. Anesth Analg 1993;77:795-800.
8. Hartung J, Cottrell JE. Nitrous oxide reduces thiopental-induced prolongation of survival in hypoxic and anoxic mice. Anesth Analg 1987;66:47-52.
9. 2O. Anesthesiology 1988;69:192-8.
10. Warner DS, Zhou J, Ramani R, et al. Nitrous oxide does not alter infarct volume in rats undergoing reversible middle cerebral artery occlusion. Anesthesiology 1990;73:686-93.
11. Hoffman W, Baughman V, Albrecht R. Interaction of catecholamines and nitrous oxide ventilation during incomplete brain ischemia in rats. Anesth Analg 1993;77:907-12.
12. Sugaya T, Kitani Y. Nitrous oxide attenuates the protective effect of isoflurane on microtubule-associated protein2 degradation during forebrain ischemia in the rat. Brain Res Bull 1997;44:307-9.
13. David HN, Leveille F, Chazalviel L, et al. Reduction of ischemic brain damage by nitrous oxide and xenon. J Cereb Blood Flow Metab 2003;23:1168-73.
14. Ingvar M, Siesjo B. Effect of nitrous oxide on local cerebral glucose utilization in rats. J Cereb Blood Flow Metab 1982;2:481-6.
15. Reasoner D, Warner DS, Todd MM, McAllister A. Effects of nitrous oxide on cerebral metabolic rate in rats anaesthetized with isoflurane. Brit J Anaesth 1990;65:210-5.
16. Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003;23:876-82.
17. Benveniste H. The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovasc Brain Metab Rev 1991;3:213-45.
18. Buchan AM, Slivka A, Xue D. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res 1992;574:171-7.
19. Minematsu K, Fisher M. MK-801 reduces extensive infarction after suture middle cerebral artery occlusion in rats. Cerebrovasc Dis 1993;3:99-104.
20. Grotta J, Picone C, Ostrow P, et al. CGS-19755, a competitive NMDA receptor antagonist, reduces calcium-calmodulin binding and improves outcome after global cerebral ischemia. Ann Neurol 1990;27:612-9.
21. Wong EW, Kemp JA, Priestley T, et al. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A 1986;83:7104-8.
22. Mackensen GB, Nellgard B, Sarraf-Yazdi S, et al. Post-ischemic RSR13 amplifies the effect of dizocilpine on outcome from transient focal cerebral ischemia in the rat. Brain Res 2000;853:15-21.
23. Kawaguchi M, Kimbro JR, Drummond JC, et al. Isoflurane delays but does not prevent cerebral infarction in rats subjected to focal ischemia. Anesthesiology 2000;92:1335-42.
24. Memezawa H, Minamisawa H, Smith ML, Siesjö BK. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res 1992;89:67-78.
25. Zea Longa E, Weinstein PR, Carlson S, Cummins RW. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84-91.
26. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats: statistical validation. Stroke 1995;26:627-35.
27. Clark WM, Lessov NS, Dixon MP, Eckenstein F. Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res 1997;19:641-8.
28. Petullo D, Masonic K, Lincoln C, et al. Model development and behavioral assessment of focal cerebral ischemia in rats. Life Sci 1999;64:1099-108.
29. Reglodi D, Tamas A, Lengvari I. Examination of sensorimotor performance following middle cerebral artery occlusion in rats. Brain Res Bull 2003;59:459-66.
30. Swanson RA, Morton MT, Tsao-Wu G, et al. A semi-automated method for measuring infarct volume. J Cereb Blood Flow Metab 1990;10:290-3.
31. Cole DJ, Matsumura JS, Drummond JC, Schell RM. Focal cerebral ischemia in rats: effects of induced hypertension, during reperfusion, on CBF. J Cereb Blood Flow Metab 1992;12:64-9.
32. Russell GB, Graybeal JM. Direct measurement of nitrous oxide MAC and neurologic monitoring in rats during anesthesia under hyperbaric conditions. Anesth Analg 1992;75:995-9.
33. Gonsowski CT, Eger EI II. Nitrous oxide minimum alveolar anesthetic concentration in rats is greater than previously reported. Anesth Analg 1994;79:710-2.
34. Stabernack C, Sonner JM, Laster M, et al. Spinal N-methyl-D-aspartate receptors may contribute to the immobilizing action of isoflurane. Anesth Analg 2003;96:102-7.
35. A-mediated chloride currents in acutely dissociated hippocampal neurons. Anesthesiology 1998; 88:473-80.
36. Hodges BL, Gagnon MJ, Gillespie TR, et al. Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade. J Pharmacol Exp Ther 1994;269:596-600.
37. Zhang C, Davies MF, Guo T-Z, Maze M. The analgesic action of nitrous oxide is dependent on the release of norepinephrine in the dorsal horn of the spinal cord. Anesthesiology 1999;91:1401-7.
38. Dietrich WD, Busto R, Alonso O, et al. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J Cereb Blood Flow Metab 1993;13:541-9.
39. Nurse S, Corbett D. Neuroprotection after several days of mild, drug-induced hypothermia. J Cereb Blood Flow Metab 1996;16:474-80.
40. Colbourne F, Li H, Buchan AM. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Stroke 1999;30:662-7.
41. Meno JR, Higashi H, Cambray AJ, et al. Hippocampal injury and neurobehavioral deficits are improved by PD 81,723 following hyperglycemic cerebral ischemia. Exp Neurol 2003;183:188-96.